Shiruyeh Schokrpur

Title(s)Assistant Professor, MED: Int Med Hematology/Oncology
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Research 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The importance of specificity of drug treatment in head and neck cancer: current developments in personalized medicine to improve safety and tolerability. Expert Rev Clin Pharmacol. 2025 Dec; 18(12):1005-1017. Champlin B, Keefe K, Birkeland AC, Schokrpur S. PMID: 41342386; PMCID: PMC12777937.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    2. Chemokine-chemokine receptor networks in conventional type I dendritic cells: an opportunity to prime and boost anticancer immunity. J Pharmacol Exp Ther. 2025 Nov; 392(11):103725. Kuo N, Shinn CK, Schokrpur S, Idoyaga J, Handel T, Gutkind JS. PMID: 41135412; PMCID: PMC12919738.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy. Nat Commun. 2025 Jul 17; 16(1):6578. Saddawi-Konefka R, Msari RA, Tang S, Philips C, Sadat S, Clubb LM, Luna S, Fassardi S, Jones R, Pietryga IF, Faraji F, Schokrpur S, Yung BS, Allevato MM, Decker KE, Nasamran CA, Chilin-Fuentes D, Rosenthal SB, Jensen SM, Fox BA, Bell RB, Gutkind JS, Sharabi A, Califano JA. PMID: 40675962; PMCID: PMC12271439.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    4. Older Adult Participation in Early-Phase Lung Cancer Clinical Trials, 1998 to 2020. JTO Clin Res Rep. 2025 Oct; 6(10):100873. Ehley D, Vardanyan L, Boxer RS, Fauer AJ, Schokrpur S, Gandara D, Riess JW, Singhal S. PMID: 40926996; PMCID: PMC12414897.
      View in: PubMed   Mentions:
    5. Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma. bioRxiv. 2025 May 06. Shinn CK, Saddawi-Konefka R, Salanga CL, Schokrpur S, Gutkind JS, Handel TM. PMID: 40654682; PMCID: PMC12247914.
      View in: PubMed   Mentions: 1  
    6. Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma. NPJ Precis Oncol. 2025 Jan 24; 9(1):24. Patel SP, Cano-Linson E, Chae YK, Schokrpur S, Lao CD, Powers BC, Victor AI, Onitilo AA, Shin S, Takebe N, Threlkel S, McLeod CM, Chen HX, Sharon E, Othus M, Ryan CW, Blanke CD, Kurzrock R. PMID: 39856213; PMCID: PMC11759674.
      View in: PubMed   Mentions: 2  
    7. The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity. J Exp Med. 2025 Mar 03; 222(2). Ferry A, Mempel KM, Monell A, Reina-Campos M, Scharping NE, Heeg M, Takehara KK, Schokrpur S, Kuo N, Saddawi-Konefka R, Gutkind JS, Goldrath AW. PMID: 39841133; PMCID: PMC11753173.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    8. KRAS G12C Inhibitors: New Drugs, A New Hope. J Thorac Oncol. 2024 Dec; 19(12):1594-1598. Singhal S, Schokrpur S, Gandara D, Riess JW. PMID: 39645298.
      View in: PubMed   Mentions:    Fields:    
    9. Let it be: Preserving tumor-draining lymph nodes in the era of immuno-oncology. Cancer Cell. 2024 Jun 10; 42(6):930-933. Saddawi-Konefka R, Schokrpur S, Gutkind JS. PMID: 38861928.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    10. Immuno-Oncology: New Insights into Targets and Therapies. Surg Oncol Clin N Am. 2024 04; 33(2):265-278. Schokrpur S, White MG, Roland CL, Patel SP. PMID: 38401909.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal Transduct Target Ther. 2023 04 17; 8(1):155. Hu J, Tan P, Ishihara M, Bayley NA, Schokrpur S, Reynoso JG, Zhang Y, Lim RJ, Dumitras C, Yang L, Dubinett SM, Jat PS, Van Snick J, Huang J, Chin AI, Prins RM, Graeber TG, Xu H, Wu L. PMID: 37069149; PMCID: PMC10110583.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    12. The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study. JTO Clin Res Rep. 2022 Dec; 3(12):100427. Benjamin DJ, Chen S, Eldredge JB, Schokrpur S, Li D, Quan Z, Chan JW, Cummings AL, Daly ME, Goldman JW, Gubens MA, Harris JP, Onaitis MW, Zhu VW, Patel SP, Kelly K. PMID: 36426286; PMCID: PMC9679033.
      View in: PubMed   Mentions: 10  
    13. UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN). J Thorac Oncol. 2023 Feb; 18(2):169-180. Bar J, Peled N, Schokrpur S, Wolner M, Rotem O, Girard N, Aboubakar Nana F, Derijcke S, Kian W, Patel S, Gantz-Sorotsky H, Zer A, Moskovitz M, Metro G, Rottenberg Y, Calles A, Hochmair M, Cuppens K, Decoster L, Reck M, Limon D, Rodriguez E, Astaras C, Bettini A, Häfliger S, Addeo A. PMID: 36307041.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    14. HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer. Cancer J. 2022 Sep-Oct 01; 28(5):339-345. Saddawi-Konefka R, Schokrpur S, Lui AJ, Gutkind JS. PMID: 36165721; PMCID: PMC9523502.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    15. Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. Nat Commun. 2022 07 25; 13(1):4298. Saddawi-Konefka R, O'Farrell A, Faraji F, Clubb L, Allevato MM, Jensen SM, Yung BS, Wang Z, Wu VH, Anang NA, Msari RA, Schokrpur S, Pietryga IF, Molinolo AA, Mesirov JP, Simon AB, Fox BA, Bui JD, Sharabi A, Cohen EEW, Califano JA, Gutkind JS. PMID: 35879302; PMCID: PMC9314425.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansAnimalsCells
    16. An overview of alectinib hydrochloride as a treatment option for ALK positive non-small cell lung cancer. Expert Opin Pharmacother. 2021 Oct; 22(14):1815-1824. Schokrpur S, Hilburn V, Giustini N, Bazhenova L. PMID: 34225542.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model. Mol Ther Methods Clin Dev. 2018 Jun 15; 9:203-210. Hu J, Schokrpur S, Archang M, Hermann K, Sharrow AC, Khanna P, Novak J, Signoretti S, Bhatt RS, Knudsen BS, Xu H, Wu L. PMID: 29766028; PMCID: PMC5948229.
      View in: PubMed   Mentions: 23  
    18. CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma. Sci Rep. 2016 Jun 30; 6:29032. Schokrpur S, Hu J, Moughon DL, Liu P, Lin LC, Hermann K, Mangul S, Guan W, Pellegrini M, Xu H, Wu L. PMID: 27358011; PMCID: PMC4928183.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    19. Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression. Prostate. 2016 10; 76(14):1293-302. Liang P, Henning SM, Schokrpur S, Wu L, Doan N, Said J, Grogan T, Elashoff D, Cohen P, Aronson WJ. PMID: 27338236; PMCID: PMC5081258.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    20. Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer. Cancer Res. 2015 Nov 15; 75(22):4742-52. Moughon DL, He H, Schokrpur S, Jiang ZK, Yaqoob M, David J, Lin C, Iruela-Arispe ML, Dorigo O, Wu L. PMID: 26471360; PMCID: PMC4675660.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    21. CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Cancer Res. 2015 Mar 15; 75(6):950-62. Escamilla J, Schokrpur S, Liu C, Priceman SJ, Moughon D, Jiang Z, Pouliot F, Magyar C, Sung JL, Xu J, Deng G, West BL, Bollag G, Fradet Y, Lacombe L, Jung ME, Huang J, Wu L. PMID: 25736687; PMCID: PMC4359956.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansAnimalsCells
    22. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY). 2009 Apr; 1(4):402-11. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Orjalo AV, Rodier F, Lithgow GJ, Campisi J. PMID: 20148189; PMCID: PMC2818025.
      View in: PubMed   Mentions: 262     Fields:    Translation:HumansCells
    23. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008 Sep 18; 27(42):5643-7. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. PMID: 18504431; PMCID: PMC2811234.
      View in: PubMed   Mentions: 316     Fields:    Translation:HumansCells
    24. The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons. Nucleic Acids Res. 2005; 33(2):714-24. Minovitsky S, Gee SL, Schokrpur S, Dubchak I, Conboy JG. PMID: 15691898; PMCID: PMC548355.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    Shiruyeh's Networks
    Concepts (117)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (41)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California